Advancing Reproductive Health Technologies
Using breakthrough cell engineering technology, Gameto is developing an ecosystem of therapeutics to support women and families through their reproductive journeys.
Women's reproductive health hasn't changed much in 40 years
Egg freezing and IVF protocols still rely on technology developed in the 1970s. Ovarian disease remains severely understudied. There are still no approved treatments for menopause. Inclusion of women in clinical trials was not even required until 1993.
Modern science tells us that the decline of female fertility is not a biological imperative. These are problems that can be solved with science.
That’s where Gameto comes in.
A platform for innovation
Gameto has developed a platform to produce female reproductive cell lines. We use proprietary cell engineering to generate ovarian cell lines that mimic the biological functions of reproductive system cells.
Our team of engineers has used this platform to build a portfolio of treatments for women’s health.
Proprietary cell engineering of reproductive cells
Reproductive cells form an ovarian organoid
The platform yields products for clinical applications
Clinical Applications
Our platform has applications across a variety of ovarian aging diseases, including infertility and menopause.
